4.5 Article

Cholesterol levels and in-hospital mortality in patients with acute decompensated heart failure

Journal

AMERICAN HEART JOURNAL
Volume 156, Issue 6, Pages 1170-1176

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.ahj.2008.07.004

Keywords

-

Funding

  1. American Heart Association (Dallas, TX)
  2. GlaxoSmithKline (Philadelphia, PA)
  3. National Institutes of Health (Bethesda, MD) [1K23HL085097]
  4. American Heart Association Pharmaceutical Roundtable [0675060N]

Ask authors/readers for more resources

Background In chronic heart failure (HF), lower total cholesterol (TC) levels have been associated with increased mortality. However, the relationship between lipid levels and outcomes in acute HF has not been studied. This study investigates the relationship between cholesterol levels and in-hospital mortality in patients hospitalized with acute HF. Methods The Get With the Guidelines-Heart Failure registry prospectively collects data on patients hospitalized with HF. We analyzed data on 17,791 patients admitted between January 2005 and June 2007 at 236 participating hospitals who had TC levels recorded. Baseline patient characteristics, treatment regimens, and in-hospital mortality were examined by TC level (mg/dL) quartiles (Q) as follows: Q1 (TC <= 118), Q2 (TC 119-145), Q3 (TC 146-179), and Q4 (TC >= 180). Results Mean TC level was 150 47 mg/dL. Patients with lower TC were older and had higher prevalence of ischemic heart disease. Of the patients, 46% were on a lipid-lowering drug, including 58%, 50%, 43%, and 34% of patients in TC Q1 to Q4, respectively. In-hospital mortality in TC Ql to Q4 was 3.3%, 2.5%, 2.0%, and 1.3%, respectively (P < .0001). On multivariable adjusted analyses, each 10-mg/dL increase in TC level was associated with 4% decreased risk of in-hospital mortality (odds ratio 0.96, 95% CI 0.93-0.98). Conclusions In patients hospitalized with HF, lower TC levels independently predict increased in-hospital mortality risk. Further evaluation of optimal cholesterol levels and influence of lipid-lowering medication use on outcomes in this population is warranted. (Am Heart J 2008;156:1170-6.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Cardiac & Cardiovascular Systems

Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review

Muhammad Shahzeb Khan, Aymen Ahmed, Stephen J. Greene, Mona Fiuzat, Michelle M. Kittleson, Javed Butler, George L. Bakris, Gregg C. Fonarow

Summary: Heart failure and end-stage kidney disease often coexist and worsen each other's prognosis. Patients on dialysis are at high risk, but they have been excluded from major clinical trials on heart failure, resulting in a lack of data and reliance on observational evidence. In clinical practice, heart failure treatment is often reduced or discontinued in patients with end-stage kidney disease undergoing dialysis due to safety concerns. This review discusses the available evidence, challenges, and future directions for optimizing heart failure management in these high-risk patients.

JOURNAL OF CARDIAC FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Achieving Equity in Hospital Performance Assessments Using Composite Race-Specific Measures of Risk-Standardized Readmission and Mortality Rates for Heart Failure

Amgad Mentias, Eric D. Peterson, Neil Keshvani, Dharam J. Kumbhani, Clyde W. Yancy, Alanna A. Morris, Larry A. Allen, Saket Girotra, Gregg C. Fonarow, Randall C. Starling, Paulino Alvarez, Milind Y. Desai, Peter Cram, Ambarish Pandey

Summary: This study found that using race-specific risk adjustment models can more accurately represent hospital performance for patients of Black and other races in terms of heart failure hospitalization and 30-day risk-standardized readmission rate and risk-standardized mortality rate.

CIRCULATION (2023)

Editorial Material Cardiac & Cardiovascular Systems

STRONG-HF and Implementing Heart Failure Therapies: Godspeed horizontal ellipsis With Care

Javed Butler, Khawaja M. Talha, Gregg C. Fonarow

CIRCULATION (2023)

Editorial Material Cardiac & Cardiovascular Systems

Target Aortic Stenosis: A National Initiative to Improve Quality of Care and Outcomes for Patients With Aortic Stenosis

Brian R. Lindman, Gregg C. Fonarow, Gary Myers, Heather M. Alger, Christine Rutan, Katie Troll, Angeline Aringo, Melanie Shahriary, Mariell Jessup, Suzanne V. Arnold, Pinak B. Shah, Wilson Y. Szeto, Clyde W. Yancy, Catherine M. Otto

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2023)

Article Cardiac & Cardiovascular Systems

Clinical Profile, Health Care Costs, and Outcomes of Patients Hospitalized for Heart Failure With Severely Reduced Ejection Fraction

Josephine Harrington, Jie-Lena Sun, Gregg C. Fonarow, Stephen B. Heitner, Punag H. Divanji, Gary Binder, Larry A. Allen, Brooke Alhanti, Clyde W. Yancy, Nancy M. Albert, Adam D. DeVore, G. Michael Felker, Stephen J. Greene

Summary: This study investigated the clinical profile and healthcare costs of US patients with heart failure who do not meet the threshold for advanced therapies. The majority of these patients have severely reduced ejection fraction (≤30%) and face increased risk of death and heart failure hospitalization despite receiving guideline-directed medical therapy.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Editorial Material Cardiac & Cardiovascular Systems

Hospital at Home as a Novel Care Strategy for Worsening Heart Failure

Hubert B. Haywood, Gregg C. Fonarow, Muhammad Shahzeb Khan, Michael E. Nassif, Javed Butler, Stephen J. Greene

JACC-HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure

Muhammad Shahzeb Khan, Sumitabh Singh, Matthew W. Segar, Muhammad Shariq Usman, Neil Keshvani, Andrew P. Ambrosy, Mona Fiuzat, Harriette G. C. Van Spall, Gregg C. Fonarow, Faiez Zannad, G. Michael Felker, James L. Januzzi, Christopher O'Connor, Javed Butler, Ambarish Pandey

Summary: This study aimed to evaluate the impact of polypharmacy on the receipt of optimal guideline-directed medical therapy (GDMT) among patients with heart failure with reduced ejection fraction (HFrEF) over time.

JACC-HEART FAILURE (2023)

Article Health Care Sciences & Services

Comparison of Machine Learning Algorithms for Predicting Hospital Readmissions and Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction: Modeling Study

Boshu Ru, Xi Tan, Yu Liu, Kartik Kannapur, Dheepan Ramanan, Garin Kessler, Dominik Lautsch, Gregg Fonarow

Summary: This study aimed to compare different machine learning prediction models and feature construction methods to predict readmissions and worsening heart failure events (WHFEs) in patients with heart failure with reduced ejection fraction (HFrEF). The results showed that the XGBoost model with the frequency of clinical codes as features had the best discriminative ability for predicting these events.

JMIR FORMATIVE RESEARCH (2023)

Article Cardiac & Cardiovascular Systems

Patterns of Referral and Postdischarge Utilization of Cardiac Rehabilitation Among Patients Hospitalized With Heart Failure: An Analysis From the GWTG-HF Registry

Neil Keshvani, Vinayak Subramanian, Christopher A. Wrobel, Nicole Solomon, Brooke Alhanti, Stephen J. Greene, Adam D. DeVore, Clyde W. Yancy, Larry A. Allen, Gregg C. Fonarow, Ambarish Pandey

Summary: This study aimed to investigate the referral and participation rates in cardiac rehabilitation (CR) among patients with heart failure with reduced ejection fraction and evaluate the impact on survival and readmission. The results showed that referral rates have increased from 2010 to 2020, but only one in four patients were referred to CR. The participation rate in CR was low. Patients referred to CR had a lower risk of 1-year death compared to those not referred.

CIRCULATION-HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Hospital at Home as a Treatment Strategy for Worsening Heart Failure

Hubert B. Haywood, Gregg C. Fonarow, Muhammad Shahzeb Khan, Harriette G. C. Van Spall, Alanna A. Morris, Michael E. Nassif, Michelle M. Kittleson, Javed Butler, Stephen J. Greene

Summary: Hospital at home is an innovative care model that is particularly suitable for heart failure patients. It provides a patient-centered and effective alternative to traditional outpatient and inpatient care. Current research supports its safety and cost-effectiveness, and new payment structures are being introduced to support its development.

CIRCULATION-HEART FAILURE (2023)

Editorial Material Cardiac & Cardiovascular Systems

Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction

Stephen J. Greene, Gregg C. Fonarow

EUROPEAN HEART JOURNAL (2023)

Editorial Material Cardiac & Cardiovascular Systems

Hospitalization for heart failure requires a PROMPT response

Nicholas K. Brownell, Gregg C. Fonarow

EUROPEAN HEART JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Prevalence of heart failure stages in the general population and implications for heart failure prevention: reports from the China Hypertension Survey 2012-15

Anping Cai, Congyi Zheng, Jiayuan Qiu, Gregg C. Fonarow, Gregory Y. H. Lip, Yingqing Feng, Zengwu Wang

Summary: The burden of heart failure (HF) in China is expected to increase due to population ageing. However, there is limited knowledge about the prevalence of HF stages in China. Therefore, this study aimed to evaluate the prevalence of HF stages in the general Chinese population and the specific prevalence by age, sex, and urbanity. The study found that both pre-clinical and clinical HF burdens are high in China and vary by age, sex, and urbanity.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Cardiac Autonomic Dysfunction and Risk of Silent Myocardial Infarction Among Adults With Type 2 Diabetes

Arnaud D. Kaze, Gregg C. Fonarow, Justin B. Echouffo-Tcheugui

Summary: In a large cohort of adults with type 2 diabetes, the study found a significant association between cardiac autonomic neuropathy (CAN) and the risk of silent myocardial infarction (SMI). Low heart rate variability was significantly associated with an increased risk of incident SMI. Participants with CAN had a 1.9-fold greater risk of SMI.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Cardiac & Cardiovascular Systems

Geographic Variation in the Quality of Heart Failure Care Among US Veterans

Revanth S. Kosaraju, Gregg C. Fonarow, Michael K. Ong, Paul A. Heidenreich, Donna L. Washington, Xiaoyan Wang, Boback Ziaeian

Summary: The burden of heart failure is increasing, and there is geographic variation in the quality of care for heart failure with reduced ejection fraction. This study evaluates the prescription of guideline-directed medical therapies (GDMT) within the Veterans Health Administration and finds significant variation across regions. Targeted strategies are needed to improve GDMT prescription in lower-performing regions, especially those affected by income inequality and poverty.

JACC-HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Realtime Diagnosis from Electrocardiogram Artificial Intelligence-Guided Screening for Atrial Fibrillation with Long Follow-Up (REGAL): Rationale and design of a pragmatic, decentralized, randomized controlled trial

Xiaoxi Yao, Zachi I. Attia, Emma M. Behnken, Melissa S. Hart, Shealeigh A. Inselman, Kayla C. Weber, Fan Li, Nikki H. Stricker, John L. Stricker, Paul A. Friedman, Peter A. Noseworthy

Summary: This study aims to explore whether Apple Watch, used as a long-term monitoring device, is effective in the early diagnosis of atrial fibrillation (AF) and the prevention of cognitive function decline in older adults. By using AI-ECG to screen high-risk patients and record electrocardiograms, the effectiveness of Apple Watch will be evaluated. If successful, this approach could have significant implications on how future clinical practice leverages consumer devices for early diagnosis and disease prevention.

AMERICAN HEART JOURNAL (2024)